QualityStocks
  The QualityStocks Daily Newsletter for Tuesday March 23rd, 2010 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters

1.

The Penny Play (CYCA)

2.

Stock Picks (LYJN)

3.

Stock Traders Chat (EVPH)


The QualityStocks Daily

TOMI Environmental Solutions, Inc. (TOMZ)

TOMI Environmental Solutions, Inc. (TOMZ) is focused on providing environmental services that use UV ozone, activated hydrogen peroxide and UVGI-Filtration to achieve a safe and healthy indoor environment. The company’s equipment will treat and protect homeland security issues that involve infectious disease control. Compared to other existing methods of air remediation and purification, TOMI systems produce byproduct-free ozone and activated hydrogen peroxide mist with a high degree of safety and industry expertise.

According to the American Medical Association (AMA), half of all illnesses may be caused or aggravated by poor indoor air quality. Recognizing this, TOMI’s mission is to ensure that everyone has an opportunity to live, work and play in a healthy indoor environment. To achieve this, the company is diligently working to educate the public about how to achieve excellent indoor air quality and its many health benefits. TOMI offers a unique suite of environmental products and services dedicated to helping consumers and organizations achieve this.

The company’s technology is deployed only by highly trained and certified technicians trained in the proper use of its products. Equipped with advanced technology, their technicians or industrial hygienists assess the air quality of commercial buildings, hospitals, schools, homes, offices, or vehicles and provide the solutions needed to eliminate allergens, asthma triggers, pathogens and contaminates.

In recent news, TOMI announced that it has put into distribution an Ultra-D Directional Mist Adaptor, a 15 foot length hose for the company’s Room Fogger Mark IV unit. Clamping easily to the fogger exhaust port, the adaptor is expected to be a game changer in the remediation and infectious disease control arena.

Dr. Halden Shane, CEO of TOMI, commented, "We are ecstatic at TOMIES to bring this accessory out of development. Using this handheld directional hose, target locations will receive a 6 log bacterial level disinfection with an average of 2-4 micron size droplets, assuring virtually no wetting, will be ideal for keyboards, desktops and other open air disinfection applications. Appropriate Personal Protective Equipment (PPE) is required by the operator. This puts our fogger into a league of its own in the control and disinfection of indoor environments and surfaces.”

He continued, “TOMIES products and applications can help eliminate the 32 billion dollar excessive healthcare costs associated with hospital acquired infections (HAI's). Irv Kraut, Industrial Hygienist and Director of Environmental Services for TOMIES, sees untapped potential revenue from the use of the Ultra-D Fogger Directional Mist Adaptor on HVAC evaporator coils, drip pans and hard and soft surfaces that are contaminated in tight and inaccessible areas. "Our fogger will be revolutionary in the air and surface remediation industry."

TOMI Environmental Solutions, Inc. (TOMZ) closed today at $0.25 on 1,209 traded shares. The stock’s 3-month daily average is 6,638 traded shares.

Utilicraft Aerospace Industries, Inc. (UITA)

Utilicraft Aerospace Industries, Inc. (UITA) is managed by a group of highly experienced aircraft executives who have accumulated decades of experience in the utility-aircraft market. This group of professionals is now focused on the design and development of humanitarian-mission-dedicated aircraft. Founded in 2004, Utilicraft Aerospace Industries trades on the pinksheets.

The company recently partnered with a veteran humanitarian shipper to further enhance its operational capabilities. Utilicraft Aerospace is well positioned to make significant strides in technology developments in assisting the efforts of groups such as the US Military. The Company is also well versed in the logistics of humanitarian air cargo movement, staging, and warehousing in the U.S. and abroad.

Utilicraft Aerospace Industries, Inc. has succeeded in building strong corporate management, engineering development management, FAA certification, and aerospace production management regarding utility aircraft. Since its inception, the company has developed "decades-long" business relationships for subcontract production management and manufacturing expertise, which brings full aerospace manufacturing capability to the company.

In most recent news, Utilicraft Aerospace announced its plans to initiate an in-house flight test program to further study the STOL utility market for its planned humanitarian relief aircraft development. Operating under an experimental certificate, the company intends to use various STOL aircraft as test-beds to analyze performance parameters for its planned development of a Light Observation Aircraft (LOA) for the Humanitarian Relief/Rescue Market.

John J. Dupont, President-CEO of Utilicraft Aerospace, commented on the initiative, saying that, “The Company will flight-test a mix of STOL aircraft to put together an optimum performance data base targeted to STOL/Utility humanitarian operations. These study runs will help solidify and expedite our operational goals for the HawkEye Program.”

Earlier this year the company also signed a Letter of Intent with the Swansea, IL based Mid America Aero LLC. As terms of the agreement, Mid America Aero would purchase ten FF-1080-300 Freight Feeder-Commercial Freight Aircrafts from Utilicraft, with an option to purchase an additional fifteen aircraft. Utilicraft has agreed to sell the Aircraft to Mid America Aero for a purchase price of $13,250,000 per Aircraft, for 10 Aircraft totaling $130,250,000 plus tax, shipping and transportation costs, and all other costs associated with U.S. and international law and requirements.

Today, Utilicraft Aerospace Industries, Inc. (UITA) closed at $0.01, even for the day, on 74,933 traded shares. The stock’s 3-month daily average is 136,180 traded shares.

QuinStreet, Inc. (QNST)

Today we choose to highlight QuinStreet, Inc. (QNST), here at the QualityStocks Daily Newsletter.

Headquartered in Foster City, California, QuinStreet, Inc. is one of the world's largest online marketing and media companies. Founded in April 1999, the Company is a top five online media buyer. Clients count on them to be the best source of customer acquisition at scale. QuinStreet, Inc. trades on the NASDAQ Global Select Market.

QuinStreet, Inc. is a search-engine marketing pioneer and is one of the largest PPC (pay-per-click) buyers in the world. The Company manages one of the largest proprietary networks on the Internet. They have expertise in every major form of online traffic. This includes their owned and operated destination sites, PPC search, third-party publishers, opt-in email, and newsletters.

The Company manages brand and regulatory compliance using proprietary technologies and staff. They do not support or use spyware, spam, or promotions that take advantage of consumers. They provide Vertical expertise and have expertise in select industry verticals, which enables them to garner the best results for their clients. Their expertise is in online messaging, segmentation, and impact in their verticals.

QuinStreet, Inc. offers online messaging, email broadcasting, search engine marketing, and brand management services. They deliver targeted results across numerous verticals. The Company caters to Education, Home Services, Financial Services, B2B, Medicine/Health, Premium Brand Advertising, Career Services, and Travel sectors. They also operate a web portal. This portal offers a comprehensive consumer information service and companion insurance brokerage service to self-directed insurance shoppers.

The Company delivers qualified clicks and qualified inquiries at low cost and with greater scalability. Their full-service approach and market-leading capabilities enable them to increase their clients' sales while reducing their clients' customer acquisition costs by as much as two-thirds.

They continually develop technologies that drive media yield, improve qualified click quality and volume, and protect their clients' brand integrity. QuinStreet, Inc. offers their Vertical Marketing Focus. They have extensive expertise in each individual vertical they serve, heightened by rigorous analytics. They offer their Targeted Media Advantage. They achieve broad reach using virtually every online media channel. This is from high-traffic placements on their company owned and operated content sites, pay-per-click (PPC) search, and third-party publishers.

QuinStreet, Inc. (QNST) closed today's trading session at $16.67, down 0.54%, on 118,967 traded shares.

Nile Therapeutics, Inc. (NLTX)

Today we choose to highlight Nile Therapeutics, Inc. (NLTX), here at the QualityStocks Daily Newsletter.

Founded in 2005, Nile Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative products for the treatment of cardiovascular disease and other areas of unmet medical needs. Headquartered in San Mateo, California, the Company is initially focusing their efforts on developing their lead compound, CD-NP. Nile Therapeutics, Inc. trades on the NASDAQ Capital Market.

The Company's CD-NP is a novel rationally designed chimeric peptide. It is in clinical development for an initial indication of acute decompensated heart failure (ADHF). Scientists at the Mayo Clinic's cardio-renal research labs rationally designed CD-NP. The design of CD-NP is to preserve the favorable effects of current therapies while preventing or attenuating the hypotensive response, and enhancing or preserving renal function. In addition to an initial indication for ADHF, CD-NP has potential use in other indications. These include preservation of cardiac function subsequent to AMI, and prevention of renal damage subsequent to cardiac surgery.

Nile Therapeutics, Inc. made progress during 2009 in the clinical development of CD-NP. In July 2009, the first patient received dosing in a single blind, placebo-controlled Phase II clinical trial. The design of the trial is to provide additional information on the safety and tolerability of CD-NP when infused for up to 72 hours in patients with acute heart failure and renal function insufficiency. The study also contains several exploratory efficacy endpoints to provide insight into the potential for CD-NP to enhance renal function in acute heart failure patients.

Thirty subjects have completed dosing in study, as of March 1, 2010. The Company submitted a protocol amendment at the end of 2009, to enable them to add up to three additional cohorts of patients, which increases potential enrollment in the study to approximately 75 patients. Interim top-line safety data from the on-going Phase II study suggests that CD-NP is well tolerated at doses of 1.25 and 2.5 ng/kg/min.

The Company expects full results from the expanded study to be available in the second half of 2010. The Company expects to initiate a Phase IIb dose-ranging, placebo-controlled, double-blind study in acute heart failure patients. This is following analysis of the ongoing Phase II data and subject to such data.

Nile Therapeutics, Inc.'s CU-NP is a novel rationally designed natriuretic peptide in pre-clinical development. CU-NP consists of amino acid chains identical to those produced by the human body, specifically the ring structure of C-type Natriuretic Peptide (CNP) and the N- and C-termini of Urodilatin (URO).

Researchers at Mayo designed CU-NP to combine the favorable hemodynamic venodilating effects of CNP generated via NPR-B receptor agonism, with the beneficial renal effects of URO generated via NPR-A receptor agonism. In-vivo studies have shown CU-NP to increase natriuresis, diuresis, and glomerular filtration rate (GFR) in a dose dependent manner. These studies have also shown CU-NP to decrease cardiac filling pressure, and inhibit the renin-angiotensin system without inducing significant hypotension.

Nile Therapeutics, Inc. (NLTX) closed Tuesday's trading at $1.10, down 1.79%, on 650 traded shares.

CommVault Systems, Inc. (CVLT)

Recently, internet.com reported on CommVault Systems, Inc. (CVLT), The Street did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

CommVault Systems, Inc. is a data-management software company. Their commitment is to giving enterprises a better way to organize, protect, and access business information. Leading technology companies globally have formed strategic partnerships with CommVault Systems, Inc. These include Dell, HDS, HP, Microsoft, NetApp, VMWare, Novell, Oracle, Sun Microsystems, and Bull. Founded in 1996, the Company has their corporate headquarters in Oceanport, New Jersey, and they trade on the NASDAQ Global Select Market.

CommVault Systems, Inc. develops Singular Information Management® solutions for high-performance data protection, universal availability and simplified management of data on complex storage networks. The Company first made their mark with the industry's leading backup software product. Today, their Solving Forward® philosophy and Simpana® software deliver complete data management solutions with scalability and control over data and costs. CommVault Systems offers their Simpana® 8 products. Their Simpana® software is a single product with licensable modules. It all undergoes building from the ground up on a single code base and common platform.

The Company's modules include Archive, Backup & Recovery, Replication, Storage Resource Management, and Search. Simpana software modules share a common set of back-end services and advanced capabilities. They "talk" to one another through the common platform.

CommVault Systems, Inc. provides dedicated support and management services for their customers. The Company offers complete consultation services for optimizing proficiency in the Simpana® platform. In addition, they provide worldwide onsite and offsite training for CommVault products.

On March 16, 2010, the Company reported that CapitalSource Bank is using CommVault® Simpana® software to safeguard critical financial and operational data dispersed across 22 branch locations throughout California, as well as a main data center and disaster recovery site. CapitalSource Bank is a Los Angeles-based retail bank with a full complement of different savings options. CapitalSource Bank is a wholly owned subsidiary of CapitalSource Inc., a publicly traded commercial finance company focused on the needs of middle-market borrowers.

CommVault technology has helped CapitalSource Bank streamline backup and recovery operations. This includes replicating data automatically to the bank's disaster recovery site to ensure the highest level of data protection.

Today, CommVault Systems, Inc. (CVLT) closed at $22.56, down 0.44%, on 182,354 traded shares.

Babcock & Brown Air Limited (FLY)

Today we choose to highlight Babcock & Brown Air Limited (FLY), here at the QualityStocks Daily Newsletter.

Trading on the New York Stock Exchange (NYSE), Babcock & Brown Air Limited acquires and leases modern, high-demand and fuel-efficient commercial jet aircraft. They do this under multi-year operating lease contracts to a diverse group of airlines globally. Founded in 2007, Babcock & Brown Air Limited has their headquarters in Dun Laoghaire, County Dublin, Ireland.

The Company has grown their fleet to 62 commercial aircraft as of November 2009. At December 31, 2009, Babcock & Brown Air Limited's aircraft were on lease to 36 lessees in 19 countries. The Company's strategy is to effectively manage their fleet and grow their portfolio through accretive acquisitions of aircraft.

Babcock & Brown Aircraft Management (BBAM), one of the world's leading aircraft lease managers with more than 25 years of experience, manages and services the Company. BBAM acts as manager of Babcock & Brown Air and servicer of the aircraft portfolio under a long-term management and servicing agreement.

BBAM arranges for the leasing of the fleet.  BBAM also assists in the acquiring and disposing of aircraft, marketeering aircraft for lease and release, and collecting rents and other payments from the lessees of aircraft. They also assist in monitoring maintenance, insurance and other obligations under leases, and enforcing Babcock & Brown Air's rights against lessees. BBAM is a wholly owned subsidiary of Babcock & Brown Air Limited.

The Company's fleet includes 57 narrow-body passenger aircraft, four wide-body passenger aircraft and one freighter. The average age of Babcock & Brown Air Limited's portfolio was 7.1 years, weighted by net book value of each aircraft at September 20, 2009. Aircraft in the Company's portfolio are subject to leases under which the lessees are responsible for operational, maintenance and insurance costs. They are also responsible for maintaining and meeting strict security, maintenance and redelivery standards. The majority of the leases include fixed rental rates.

On March 4, 2010, Babcock & Brown Air Limited announced their financial results for the Fourth Quarter and full year of 2009. Fourth Quarter 2009 highlights include Net income of $13.7 million and EPS of $0.45. Highlights also include a Fourth Quarter dividend of $0.20 per share paid on February 19, 2010.

2009 Full Year Highlights include Net income of $89.1 million, and EPS of $2.89. Total cash increased to $235.2 million at year-end. In addition, the Company paid total annual dividends of $0.80 per share.

Babcock & Brown Air Limited (FLY) closed today at $10.38, up 0.58%, on 62,089 traded shares.

Newalta Corporation (NAL.TO)

We are highlighting Newalta Corporation (NAL.TO), here at the QualityStocks Daily Newsletter.

Trading on the Toronto Stock Exchange, Newalta Corporation provides cost-effective solutions to industrial customers to improve their environmental performance. The Company's focus is on recycling and recovery products from industrial residues. Newalta Corporation has their corporate headquarters in Calgary, Alberta. They have offices in Burlington, Ontario, Brossard, Quebec, and Dartmouth, Nova Scotia.

Newalta is a leader in Canada's industrial waste management and environmental services industry. They have received recognition as one of Canada's "Superbrands" by a council of marketing experts. This is for the Company's commitment to premium services. They have a strong base in the West, are well established in Ontario and growing their business through Quebec and Atlantic Canada.

The Company provides their services through their network of 80 facilities across Canada. They also provide services at their customers' facilities where they mobilize their equipment and people to process material directly onsite. Newalta Corporation's customers operate in a wide range of industries. These include the oil and gas, petrochemical, refining, lead, manufacturing and mining industries.

For the Company's Western Division, Newalta has their facilities in B.C., Alberta and Saskatchewan. They deliver waste management, commodity recovery and environmental services to the oilfield sector and to industrial operations in Western Canada and bordering states.

For their Eastern Division, the Company has facilities in Ontario, Quebec, Newfoundland, Nova Scotia and New Brunswick. They deliver waste management and environmental services to industrial businesses throughout Central and Eastern Canada. They also deliver these services to the oilfield sector in Atlantic Canada as well as in bordering states.

The Company works with their customers' drilling, logistics, and environment, health and safety teams. They manage waste and provide the environmental services and oversight needed for compliance.

On March 15, 2010, Newalta Corporation announced that they declared a quarterly cash dividend of $0.05 per common share for the first quarter of 2010, payable on April 15, 2010, to all shareholders of record on March 31, 2010. The ex-dividend date is March 29, 2010.

Newalta Corporation (NAL.TO) closed Tuesday's session at $8.71, up 2.59%, on 85,437 traded shares.

Conceptus, Inc. (CPTS)

Zacks.com reported earlier on Conceptus, Inc. (CPTS), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Conceptus, Inc. is a leader in the design, development and marketing of innovative solutions in women's healthcare. Trading on the NASDAQ Global Market, the Company manufactures and markets Essure permanent birth control. The Essure procedure is available in the United States, Europe, Australia, New Zealand, Canada, Mexico, Central and South America and the Middle East. Conceptus, Inc. has their headquarters in Mountain View, California.

In 2002, the U.S. Food and Drug Administration (FDA) granted approval to market the Essure® device in the United States. This is a market where more than 700,000 tubal ligations, the leading form of birth control, and 400,000 vasectomies take place each year. The Essure procedure is the first permanent birth control method that can be performed in a physician's office in less than10 minutes. This is without hormones, cutting, burning or the risks associated with general anesthesia or tubal ligation.

Small, flexible micro-inserts undergo placement in a woman's fallopian tubes through the cervix without incisions. The body forms a natural barrier around the micro-inserts over the next three months. This is to prevent sperm from reaching the egg.

A doctor performs an Essure Confirmation Test three months after the Essure procedure. This is to confirm that the micro-inserts have undergone proper placement and the fallopian tubes are fully blocked, giving the patient reliance on Essure for permanent birth control. More than 370,000 women globally have undergone the Essure procedure.

Essure is 99.8 percent effective based on four years of follow up. This is with zero pregnancies reported in clinical trials. This makes it the most effective form of permanent birth control on the market. Clinical data also proves that the Essure procedure allows for a fast recovery and has a high patient satisfaction rating. Almost all women rated their satisfaction with the Essure procedure as "good" to "excellent" after the first week.

The Essure procedure has had featuring in reputable sources. These sources include Time Magazine, MSNBC.com, and The Doctors show. It has become the standard of care for many healthcare organizations and professionals.

Conceptus, Inc. (CPTS) closed Tuesday's trading at $21.17, up 0.24%, on 237,980 traded shares.

The QualityStocks Company Corner

Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today Consorteum Holdings, Inc. closed trading at $0.009, which was even for the day. Their volume today was 953,950 traded shares.

Consorteum Holdings, Inc. (CSRH) announced today that it has entered into a non-binding Letter of Intent to acquire Tenzing Interactive. If finalized, Tenzing Interactive will be a wholly owned subsidiary of Consorteum Inc. According to the terms of the agreement, the purchase price is to be payable over a 2-year period and made up of a combination of cash and shares in Consorteum Holdings Inc.

Consorteum Holdings, Inc. (CSRH) provided a corporate update today. Consorteum Holdings will now focus on leveraging the previously announced new relationships to provide better value added services to their clients.

Consorteum Holdings, Inc. (CSRH) is focused on providing financial services, electronic transaction processing and management services to financial institutions, healthcare, government, public and private sector companies. The company’s services provide customized, innovative technology solutions that create, augment and enhance their clients’ existing financial, payment and transactional processing systems.  

The company offers clients a long-term strategic plan utilizing the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create exceptionally customized programs. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new revenues. 

Consorteum’s strategy is to capitalize on the global opportunities within the growing financial services, payment and transaction processing marketplace. The utilized business model generates revenues on every transaction touched, thus providing long-term, sustainable income. The company has strategically designed its business initiatives to create significant repetitive transactions on an ongoing basis. Additional company revenues are generated from consulting services, project minimums and management fees. 

The company is jointly led by CEO Craig Fielding and President & COO Quent Rickerby. Mr. Fielding brings a wealth of expertise in the payments industry, in both local and international payment processing, along with HR-specific business management expertise, leadership, customer development and acquisition skills. Mr. Rickerby brings over two decades of business management, international and domestic sales experience, new company start-up, payment processing, project management, business development, negotiations, relationship management and strategic company direction.Disclaimer

Consorteum Holdings, Inc. Blog

Consorteum Holdings, Inc. News:

Consorteum Holdings Inc. Provides Business Update and Corporate Review

Consorteum Holdings Inc. Appoints Past Chairman & CEO of McDonald's Japan to Board of Advisors

Consorteum Holdings Inc. Launches International Payroll and Multi-Currency Service

Newport Digital Technologies, Inc. (NPDT)

The QualityStocks Daily Newsletter would like to spotlight Newport Digital Technologies, Inc. (NPDT).  Today Newport Digital Technologies, Inc. closed trading at $0.0161, which was down 1.83 percent. Their volume today was 1,530,084 traded shares. 

Newport Digital Technologies, Inc. (NPDT) offers a rich portfolio of competencies in RFID (Radio-Frequency Identification), WiMAX, eLearning, LED Signage, and Security & Surveillance. Utilizing its technological expertise and creativity, the company enables its customers to take full advantage of the nearly limitless possibilities offered by increasingly sophisticated applications.

Newport is committed to meeting specific customer requirements by delivering complete solutions for a broad spectrum of applications. The company is building a global distribution, licensing, and sales network of industry-leading partners as well as third-party Original Design Manufacturers (ODMs) and component suppliers to ensure its clients world-leading technology with strong local support capabilities.

The company has established a synergistic partnership with Taiwan’s premier technology incubators, the Institute for Information Industry (III) and the Industrial Technology Research Institute (ITRI), under which the company develops and customizes their advanced technologies to meet the needs of businesses across the globe. Having a pool of more than 7,900 engineers and scientists, these R&D powerhouses have developed cutting edge capabilities in fields such as Information Communications Technology (ICT), electronics, and nanotechnology.

Newport’s management team has accumulated a wealth of knowledge and experience within the technology industry as well as the corporate world. Maintaining a strong track record of delivering results to investors and customers, the team retains over two centuries of combined experience. Leveraging each team member’s area of expertise, Newport has established a solid foundation to penetrate emerging technology markets.Disclaimer

Newport Digital Technologies, Inc. Blog

Newport Digital Technologies, Inc. News:

Newport Digital Technologies, Inc. Announces the Appointment of Steve Ruey-Long Chen, Former Minister of the Ministry of Economic Affairs of Taiwan, to the Advisory Board

Newport Digital Technologies, Inc. to Exhibit at RFID Journal Live! 2010 - April 14-16, at the Orange County Convention Center, in Orlando, Fla.

CORRECTING and REPLACING Newport Digital Technologies Develops First LED Digital Signage Solution with Wi-Fi, 3G and WiMax Wireless Connectivity

eDOORWAYS Corporation (EDWY)

The QualityStocks Daily Newsletter would like to spotlight eDOORWAYS Corporation (EDWY) Today eDOORWAYS Corp. closed trading at $0.012, which was even for the day. Their volume today was 2,464,420 traded shares. 

eDOORWAYS Corp. (EDWY) is committed to solving lifestyle problems for consumers while driving traffic to suppliers and service providers who offer innovative merchandise and solutions. The company has the potential to completely change the future landscape of business by offering a unique and comprehensive service that saves consumers valuable time and money. By uniting a consumer with the larger global consumer community, retailers, and manufacturers in an effective new way, eDOORWAYS promotes “dynamic” commerce, as opposed to the static model currently in existence.

The Company plans to capitalize on several emerging new trends. These newly created opportunities include: the large success of Web 2.0 Internet community service offerings such as MySpace, the movement towards niche marketing and targeted advertising, the introduction of new technologies that enable instantaneous, online presentation of information, and the rising consumer preference for using the Internet to gain information before making purchasing decisions.

eDOORWAYS plans to introduce local services using a city-by-city strategy that will minimize capital requirements, reduce staffing requirements, and optimize generated revenues. Ten major cities are targeted for launch in the first year. Advertising, PR campaigns and viral word-of-mouth will be used to give a public presentation to experts as well as educate the market.

The key benefits offered to consumers include a higher level of engagement with vendors, trusted information from other consumers, and superior customer service. Revenues will be generated through advertising placement fees, premium services, preferential placement fees, and a percentage of sales transactions. eDOORWAYS' progressive vision and professional management team makes it an attractive investment opportunity. Disclaimer

eDOORWAYS Corporation Blog

eDOORWAYS Corporation News:

eDoorways Impresses Convention Goers at SXSW's Interactive Festival - Increasing Online User Base

eDoorways' Involvement in SXSW Should Demonstrate Company's Focus -- With a Peek at v2.5

eDoorways Announces Participation in SXSW

Energtek, Inc. (EGTK)

The QualityStocks Daily Newsletter would like to spotlight Energtek, Inc. (EGTK). Today Energtek, Inc. closed trading at $0.225, which was down 2.17 percent. Their volume today was 124,249 traded shares. 

Energtek, Inc. (EGTK) is focused on developing and commercializing Adsorbed Natural Gas (ANG) technology. This tecshnology enables the storage of comparable gas quantities at reduced pressure, dramatically decreasing the capital investment and operational costs of natural gas vehicles. The company recognizes the global markets' demands to diversify energy sources and is working on breakthrough technologies that deliver natural gas to the consumer, even where no gas pipeline and compressing infrastructure exist.

Because natural gas is cheaper, cleaner and available in greater quantities than oil, Energtek believes it is the most practical motor fuel alternative. Natural gas is primarily comprised of methane, which is one of the simplest and most abundant substances found in nature, especially when compared to oil. Taking advantage of natural gas resources located across the globe will also reduce the number of countries forced to import motor fuel, including the USA.

The percentage of Natural Gas Vehicles (NGVs) in many countries is growing rapidly. Today, there are more than 8.7 million NGVs on the road, a number that is growing by more than 30% per year. Even with this robust growth, NGVs still represent only a small percentage of the overall vehicle market. Until now, costly refueling infrastructure, as well as the inconvenience of integrating NG tanks into vehicles, has limited the growth of NGVs. However, by enabling the use of natural gas in places previously impossible, Energtek's proprietary ANG technology promises to greatly expand the NGV market.

CEO Lev Zaidenberg leads the company with extensive experience starting and managing several successful hi-tech companies in Israel, Europe and the USA. Mr. Zaidenberg received a B.Sc. in Applied Mathematics and an MBA from Tel-Aviv University. Professor Yuri Ginzburg serves alongside Zaidenberg with a PhD / D.Sc in Mechanical Engineering and a comprehensive background in the automotive industry. Ginzburg is a specialist in alternative fuel systems and R&D projects management, and has authored 18 patents and over 70 scientific works. Disclaimer

Energtek, Inc. Company Blog

Energtek, Inc. News:

Energtek Completes Production of World's First LMP(TM) Low-pressure Semi-Trailer

Energtek Identifies Commercial Consumer for Natural Gas Extracted on Site in Israel

Energtek Anticipates Increase of NatGas Activities in India and FMC Technologies Awarded $30 Million Contract for StatoilHydro's Peregrino Project

Consorteum Holdings, Inc. (CSRH) Announces Letter of Intent to Acquire Tenzing Interactive

Today before the opening bell, Consorteum Holdings, Inc. announced that it has entered into a non-binding Letter of Intent to acquire Tenzing Interactive. If finalized, Tenzing Interactive will be a wholly owned subsidiary of Consorteum Inc. According to the terms of the agreement, the purchase price is to be payable over a 2-year period and made up of a combination of cash and shares in Consorteum Holdings Inc.

The proposed acquisition is part of Consorteum Holdings’ intent to expand both local and international opportunities. Tenzing Interactive will bring with it new value added partners, allowing Consorteum to achieve its long term business strategy, increase revenues of current initiatives and add new opportunities to generate additional income. Combining Tenzing Interactive’s approach to enhancing its clients’ brand recognition with Consorteum Holdings’ ability to add transaction based initiatives will increase revenues and value to all parties, including the client.

Craig Fielding, CEO of Consorteum Holdings Inc. stated, “The market for our solutions is expanding rapidly. This new collaboration will allow us to significantly grow our current business opportunities while bringing on contracts in new areas. The ability to expand existing client agreements and take advantage of new international opportunities puts both Consorteum Holdings and Tenzing Interactive in a strong position to increase revenues and shareholder value.”

If a definitive agreement cannot be concluded, then terms of the agreement provide the option for a joint venture between both companies. Consequently, current and new clients will benefit from Tenzing’s branding solutions and Consorteum’s transaction solutions. Revenues to the joint venture would accordingly be shared.

Cellceutix Corp. (CTIX) “Low Key” About Product Developments

Yesterday we had a discussion with Mr. Leo Ehrlich, Chief Financial Officer of Cellceutix. Mr. Ehrlich is a very low-key gentleman, but inspired us to want to continue research into CTIX. The first item of discussion in our conversation included the fact that a major cancer hospital (no name was mentioned) will be doing the clinical studies on Kevetrin, their flagship product designed to treat cancer cells that do not respond to typical treatments. Cellceutix hopes that the clinical studies will commence in the third or fourth quarter of this year. Which quarter the studies will begin is dependent on the IND filing process going smoothly with the Food and Drug Administration.

Mr. Ehrlich also confirmed that their share structure still only contains approximately 90 million shares outstanding and a float of around 45 million. There is a high percentage of shares held by insiders, but the percentage was not verified. This helps explain the low volume totals on a daily basis.

Another item that was briefly discussed is the great financial lengths that Mr. Ehrlich, Dr. Krishna Menon, Chief Scientific Officer of Cellceutix, and Mr. George Evans, CEO of Cellceutix, have personally gone to with the company. They have invested a great deal of their personal money to develop the company and its products. Mr. Evan’s background at Pfizer, Inc. was briefly discussed. The CEO has more than 25 years biotechnology experience and ended his career at Pfizer as General Counsel of their worldwide prescription drug unit and a member of the unit’s leadership team.

A final bit of the conversation included the autism product that they have in the pipeline. It is very unique and will be creating big news as development progresses and Cellceutix begins issuing more data and information regarding the treatment.

We have spoken with many companies over the years that trade on the OTCBB market and one thing that struck us about Cellceutix Corporation was not only their concern for shareholder value, but the manner in which they carry themselves as a company. They appear to have some ground-breaking pharmaceuticals in development and are still maintaining a low-profile despite extremely positive pre-clinical research. A bit of a different approach from an OTC Bulletin Board company to say the least.

Drinks Americas Holdings Ltd. (DKAM) Announces Improved Fiscal 2010 Third Quarter Operating Results

Drinks Americas Holdings Ltd. develops, owns, markets and nationally distributes alcoholic and non-alcoholic premium beverages associated with renowned icon celebrities. Some of their beverages include Trump Super Premium Vodka and Willie Nelson’s Old Whiskey River Bourbon. The company today announced results for the fiscal third quarter ended January 31, 2010.

In the third quarter, the company shipped and sold approximately $397,000 in new product. This revenue exceeded Drinks Americas’ previous forecast. As reported previously by the company, its second fiscal quarter had only generated $15,000 in shipments and revenues. This low figure was due to severe working capital restraints.

The company reduced selling, general and administrative expenses by 60 percent in the fiscal third quarter as compared to the fiscal second quarter. As a result of the reconfiguration of the company’s business model, Drinks Americas’ annual overhead will continue to be reduced from a historical run rate of more than $4.8 million annually to approximately $1.2 million annually.

As a result of various negotiations, Drinks Americas has reduced its third quarter payables and short-term debt by $383,000 from the last fiscal quarter. In addition, the company has paid down $200,000 of its long-term debt. Drinks Americas also recently announced a venture with Mexcor International Wine and Spirits to accelerate the company’s growth.

Drinks Americas’ CEO, J. Patrick Kenny, stated. “We believe that our third quarter results reflect the improvements in operations that we have implemented over the past six months. We have stabilized our operations, allowing us to again focus on growing revenue through both existing and new distribution channels. We have strengthened our balance sheet…which should allow us to become profitable as Mexcor increases distribution of our products.”

GeoVax Labs, Inc. (GOVX) Appoints Two Industry Veterans to Board of Directors

GeoVax Labs Inc. is a biotechnology company developing human vaccines for HIV/AIDS and other infectious diseases. The company announced today that it has elected Steven Antebi and David A. Dodd to its board of directors. These appointments bring the number of board members to eight, five of whom are considered independent.

Since 1993, Mr. Antebi has been the president and chairman of the board of Maple Capital Management, an equity fund focused on investments in North America. He is also president and CEO of Galileo Partners LLC and president of Blue and Gold Enterprises Inc. These funds invest in registered direct investments, PIPE transactions, private placements and open market equity transactions. Prior to that, he served in various senior positions at Bear Stearns. Since 2009, Mr. Antebi has served as chairman of the board of Epinex Diagnostics and he has also served as a member of the board of governors of Cedars Sinai Hospital. All together, Mr. Antebi has nearly 30 years of financial industry expertise and experience in business development and management in the healthcare, technology and interactive media industries.

Mr. Dodd is the CEO of RiversEdge BioVentures, an investment and advisory firm focused on life sciences and pharmaceuticals, which he founded in 2009. He has more than 35 years of executive experience in the healthcare industry. From December 2007 to June 2009, Mr. Dodd was president, CEO and chairman of BioReliance Corporation, a company that provided biological safety testing, viral clearance testing, genetic and mammalian technology testing and laboratory animal diagnostic services testing. From October 2006 to April 2009, he served as non-executive chairman of Stem Cell Sciences PLC. Before that, Mr. Dodd served as president, CEO and director of Serologicals Corporation. This followed his five-year stint as president and CEO of Solway Pharmaceuticals and chairman of its subsidiary, Unimed Pharmaceuticals.

Geovax’s chairman of the board, Don Hildebrand, commented on the appointments, “Steven Antebi and David Dodd bring a tremendous amount of experience and innate ability to GeoVax. Their knowledge of business development and management as well as of the healthcare field is extraordinary, and we expect to rely on their professional acumen, experience and insights into capital formation as we work to accelerate our HIV/AIDS vaccine programs.”

 


Sponsors of the Day

 

The QualityStocks Public Company Sponsor News

QualityStocks


 

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-374-1336